[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fXzqiiN1-UBxtj2SP6Q7uw0v8dBpyS8rRtNk9tckPAww":8,"$fwn4pK2kwgcpjy0pK8tTNzXf0fCPaFt17vfqjrEIdSYA":56,"$fpiQx14fzHvJT1jX33GBvxytNeqlIgIwFg3kiehEut6k":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":33,"menus":34,"menuId":36,"type":43,"quality":54,"commentCount":21,"isComment":43},74979,867271,[],"https://ystcdn.venuertc.com/medical/ystApp/1KNmXQDnP2XagGmzBK1qyfRfTWA6Qk1r.png","李浩齐","缙云县新建镇中心卫生院","全科医疗","住院医师",516,0,"肺鳞状细胞癌相关药品 | 用药安全与实用细节全指南","","https://ystcdn.venuertc.com/venue/AI/ba292456-369f-45b3-b004-18838d13bd54.jpg","\u003Cdiv class=\"material-main-wrap\">\n  \n  \u003Ch1 id=\"material_title\" class=\"material-title\">肺鳞状细胞癌相关药品 | 用药安全与实用细节全指南\u003C/h1>\n  \n  \n  \u003Csection class=\"material-intro-block\">\n    \u003Cdiv class=\"material-block-bg material-bg-1\">\n      \u003Cp class=\"material-intro\">提及免疫治疗、白蛋白紫杉醇、卡铂、以及辅助药物（如胃黏膜保护剂、抗凝药等），不少人在用药环节有很多疑问。其实这些药物无论联合还是单独使用，都有不少值得关注的用药细节和风险防控要点。下面就针对以上药品的安全用药方法、特性、剂量调整、注意事项、不良反应、储存技巧等7大环节，为大家梳理最实用的2500字药品操作手册。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \n  \u003Csection class=\"material-catalog-block\">\n    \u003Cdiv class=\"material-block-bg material-bg-2\">\n      \u003Cul class=\"material-catalog-ul\">\n        \u003Cli>1️⃣ 免疫治疗药物的用药操作要点\u003C/li>\n        \u003Cli>2️⃣ 白蛋白紫杉醇使用建议与禁忌\u003C/li>\n        \u003Cli>3️⃣ 卡铂的安全服用方法\u003C/li>\n        \u003Cli>4️⃣ 辅助用药（胃黏膜保护剂、抗凝药、糖皮质激素）的操作细节\u003C/li>\n        \u003Cli>5️⃣ 药物相互作用：联合时务必注意什么？\u003C/li>\n        \u003Cli>6️⃣ 不同人群如何安全调整剂量？\u003C/li>\n        \u003Cli>7️⃣ 药物副作用、安全储存与特殊情况应对\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n\n  \n  \u003Csection class=\"material-section-block\">\n    \u003Cdiv class=\"material-block-bg material-bg-3\">\n      \u003Ch2 class=\"material-subtitle\">1️⃣ 免疫治疗药物的用药操作要点\u003C/h2>\n      \u003Cp>免疫治疗药物（如免疫检查点抑制剂）在肿瘤用药中占有重要地位，大多通过抑制PD-1/PD-L1信号通路提升自体免疫细胞识别异常细胞的能力\u003Csup>[1]\u003C/sup>。\u003C/p>\n      \u003Cul class=\"material-ul\">\n        \u003Cli>\n          \u003Cb>剂型和规格：\u003C/b>目前多为注射剂型，常用浓度有100mg、200mg等规格，具体根据药品说明书为准。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>最佳用药时间及方式：\u003C/b>静脉输注为主，常规为每3周一次，每次剂量200mg。输注时间30-60分钟，严禁自行更改给药途径。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>服药环境：\u003C/b>需在医疗机构内由专业护理人员操作，确保用药安全。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>特殊饮食要求：\u003C/b>没有明确的饮食禁忌，但用药当天建议清淡饮食，保持身体状态良好。\n        \u003C/li>\n        \u003Cli>正确做法：用药前询问医师近期感冒、感染情况，勿随意停用/更改频率。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n\n  \n  \u003Csection class=\"material-section-block\">\n    \u003Cdiv class=\"material-block-bg material-bg-4\">\n      \u003Ch2 class=\"material-subtitle\">2️⃣ 白蛋白紫杉醇使用建议与禁忌\u003C/h2>\n      \u003Cul class=\"material-ul\">\n        \u003Cli>\n          \u003Cb>主要成分：\u003C/b>紫杉烷类药物，配以白蛋白，减少溶剂相关反应\u003Csup>[2]\u003C/sup>。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>作用机制：\u003C/b>干扰细胞微管装配，妨碍细胞有丝分裂，有效抑制肿瘤生长。\u003Cbr>\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>剂量和服用方式：\u003C/b>\n          \u003Cul>\n            \u003Cli>剂量按体表面积计算，常见方案为每周注射一次或每3周一次。\u003C/li>\n            \u003Cli>需经专业医师依体重、肝肾功能等参数调整。\u003C/li>\n            \u003Cli>不可自行口服，必须采用静脉滴注。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>避免人群：\u003C/b>对紫杉烷类、白蛋白过敏者禁用；有严重肝功能不全者慎用。\n        \u003C/li>\n        \u003Cli>用药过程中需化验血常规，如出现严重白细胞减少，及时告知医护。\u003C/li>\n        \u003Cli>\n          \u003Cb>服用小技巧：\u003C/b>滴注部位应定期更换，观察局部有无红肿渗出。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-case-block\">\u003Cspan class=\"case-emoji\">📝\u003C/span>一位老年患者化疗联合白蛋白紫杉醇后发生轻度食欲减退，调整支持用药后恢复正常。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n\n  \n  \u003Csection class=\"material-section-block\">\n    \u003Cdiv class=\"material-block-bg material-bg-5\">\n      \u003Ch2 class=\"material-subtitle\">3️⃣ 卡铂的安全服用方法\u003C/h2>\n      \u003Cul class=\"material-ul\">\n        \u003Cli>\n          \u003Cb>成分与剂型：\u003C/b>卡铂为铂类抗肿瘤药，常见为注射液剂型。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>作用机制：\u003C/b>可与DNA形成交联，干扰其复制和转录过程从而杀伤增殖活跃的细胞。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>用药方法：\u003C/b>\n          \u003Cul>\n            \u003Cli>剂量常按按照AUC（暴露量）和肾功能计算。\u003C/li>\n            \u003Cli>一般为3～4周一次静脉输注，用量和周期由医师结合化验结果调整。\u003C/li>\n            \u003Cli>使用前需检查肾功能。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>服用细节：\u003C/b>输注前多补充水分，输液结束后监测尿量。\n        \u003C/li>\n        \u003Cli>用药期间出现听力下降、乏力等需及时报告。\u003C/li>\n        \u003Cli>\n          \u003Cb>禁忌组别：\u003C/b>已知对铂制剂过敏者禁止使用，有严重肾功能不全、骨髓功能抑制患者不建议使用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-case-block\">\u003Cspan class=\"case-emoji\">🔍\u003C/span>临床上有患者在用卡铂期间因肾功能异常暂停用药，经调整治疗后恢复方案。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \n  \u003Csection class=\"material-section-block\">\n    \u003Cdiv class=\"material-block-bg material-bg-6\">\n      \u003Ch2 class=\"material-subtitle\">4️⃣ 辅助用药的操作细节\u003C/h2>\n      \u003Cul class=\"material-ul\">\n        \u003Cli>\n          \u003Cb>胃黏膜保护剂（如质子泵抑制剂）：\u003C/b>\n          \u003Cul>\n            \u003Cli>剂型多为口服片剂/胶囊，常见的有奥美拉唑、艾普拉唑等。\u003C/li>\n            \u003Cli>建议餐前30分钟用温水吞服，不可咀嚼或掰碎。\u003C/li>\n            \u003Cli>若出现胃部不适，可与小量温水或流食同服。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>抗凝药（如低分子肝素钠）：\u003C/b>\n          \u003Cul>\n            \u003Cli>多为皮下注射型。\u003C/li>\n            \u003Cli>每日1~2次，根据体重、凝血监测结果调整剂量。\u003C/li>\n            \u003Cli>皮下注射部位应轮换，避免皮下瘀青或硬结。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>糖皮质激素（如地塞米松）：\u003C/b>\n          \u003Cul>\n            \u003Cli>用于部分药物引起的不良反应预防或缓解。\u003C/li>\n            \u003Cli>剂型有口服片剂和注射剂。\u003C/li>\n            \u003Cli>遵医嘱调整剂量和疗程，不可随意增减用量或突然停药。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n\n  \n  \u003Csection class=\"material-section-block\">\n    \u003Cdiv class=\"material-block-bg material-bg-7\">\n      \u003Ch2 class=\"material-subtitle\">5️⃣ 药物相互作用：联合用药的4个关键点\u003C/h2>\n      \u003Cul class=\"material-ul\">\n        \u003Cli>\n          \u003Cb>1）白蛋白紫杉醇与CYP酶抑制剂：\u003C/b>同期使用某些抗生素（如红霉素）、抗真菌药，可能延缓紫杉醇代谢，提高毒性。建议间隔至少12小时。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>2）卡铂与肾毒性药物：\u003C/b>如同时服用氨基糖苷类抗生素，肾损风险加大，应避免合用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>3）免疫治疗药物与糖皮质激素：\u003C/b>糖皮质激素大剂量可降低免疫药物疗效。需权衡利弊、医师决定。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>4）抗凝药与非甾体抗炎药（NSAIDs）：\u003C/b>两者同用易增加出血风险。应严格控制合用时间与剂量，并监测凝血指标。\u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"material-focus\">\n        正确做法：使用多种药物时主动向医师、药师报告全部用药种类和补品，防止“药物打架”。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n\n  \n  \u003Csection class=\"material-section-block\">\n    \u003Cdiv class=\"material-block-bg material-bg-8\">\n      \u003Ch2 class=\"material-subtitle\">6️⃣ 不同人群的剂量管理须知\u003C/h2>\n      \u003Cul class=\"material-ul\">\n        \u003Cli>\n          \u003Cb>老年人：\u003C/b>药物代谢能力下降，白蛋白紫杉醇与卡铂应低剂量起始，密切监测肝肾功能，定期复查血常规。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>肝肾功能减退患者：\u003C/b>白蛋白紫杉醇、卡铂剂量需根据肝酶和肾小球滤过率调整，部分辅助用药（如抗凝药）也需改小剂量或延长给药间隔。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>特殊体重人群：\u003C/b>极瘦、极重人群的剂量要个体化计算，避免过量或疗效不足。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>孕妇及哺乳期妇女：\u003C/b>这几类主要药物均存在胎儿/婴儿生长发育风险。如非必须，原则上禁止使用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>儿童：\u003C/b>绝大多数抗肿瘤药仅限成人人群，儿童如需用药需由专科医师提出个体化用药计划。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n\n  \n  \u003Csection class=\"material-section-block\">\n    \u003Cdiv class=\"material-block-bg material-bg-9\">\n      \u003Ch2 class=\"material-subtitle\">7️⃣ 药物副作用、安全储存与特殊应对方法\u003C/h2>\n      \u003Cul class=\"material-ul\">\n        \u003Cli>\n          \u003Cb>常见不良反应：\u003C/b>\n          \u003Cul>\n            \u003Cli>免疫治疗药：皮疹、乏力、轻度肝酶升高；极少数可致严重免疫异常。\u003C/li>\n            \u003Cli>白蛋白紫杉醇：可能有食欲不佳、脱发、手麻脚麻、肝功能升高。\u003C/li>\n            \u003Cli>卡铂：容易引发骨髓抑制、恶心呕吐、肾功能变化、听力下降等。\u003C/li>\n            \u003Cli>辅助药物：部分抗凝药可有皮下出血、质子泵抑制剂长用需注意胃肠道菌群变化。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>不良反应处理：\u003C/b>大部分副反应为可逆，一旦出现严重呕吐、明显黄疸、持续发热等，及时前往医院。\u003C/li>\n        \u003Cli>\n          \u003Cb>药品储存：\u003C/b>\n          \u003Cul>\n            \u003Cli>原厂包装避光密封，10℃~25℃干燥环境保存，辅助药品如低分子肝素可冷藏。\u003C/li>\n            \u003Cli>开封后严禁久置，液体制剂建议用后一周内弃去。\u003C/li>\n            \u003Cli>过期变色药物严禁继续使用。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>漏服与过量：\u003C/b>多为医院操作，如出现输注中断、剂量异常，严禁自行补药或调量。必须寻求医护专业处理。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-case-block\">\u003Cspan class=\"case-emoji\">⚠️\u003C/span>有患者因存放不当导致辅助用药失效，故每次服用前都需核对药品完整性与有效期。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n\n  \n  \u003Csection class=\"material-outro-block\">\n    \u003Cdiv class=\"material-block-bg material-bg-10\">\n      \u003Ch3 class=\"material-summary-title\">🔑 结语与实用要点小结\u003C/h3>\n      \u003Cp class=\"material-summary-key\">\n        回顾主要药品的用药安全细节：\u003Cbr>\n        \u003Cspan class=\"material-highlight\">1\u003C/span>、免疫治疗和化疗药物须在医疗机构操作，不可私自更换给药方法；\u003Cbr>\n        \u003Cspan class=\"material-highlight\">2\u003C/span>、联合用药要防“药物打架”，如同时用多种药品须主动向医师说明；\u003Cbr>\n        \u003Cspan class=\"material-highlight\">3\u003C/span>、注意储存、服用和剂量调整的每一步，确保服药安全；\u003Cbr>\n        \u003Cspan class=\"material-highlight\">4\u003C/span>、不适时要及早与医生沟通，防止延误处理。\u003Cbr>\n        \u003Cbr>\n        科学、安全用药才能更好发挥作用。任何用药疑问可咨询专业药师，让每一次用药都安心、有保障。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \n  \u003Csection class=\"material-ref-block\">\n    \u003Cdiv class=\"material-block-bg material-bg-ref\">\n      \u003Ch4 class=\"material-ref-title\">参考文献\u003C/h4>\n      \u003Col class=\"material-ref-ol\">\n        \u003Cli>Larkin J, Chiarion-Sileni V, Gonzalez R et al. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med. 2015;373(1):23-34.\u003C/li>\n        \u003Cli>Gradishar WJ, et al. Albumin-bound paclitaxel: A next-generation taxane. Expert Opin Pharmacother. 2013;14(15):2107-2121.\u003C/li>\n        \u003Cli>Calvert AH, et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol. 1989;7(11):1748-1756.\u003C/li>\n        \u003Cli>Garon EB, et al. Pembrolizumab for the treatment of non–small-cell lung cancer. N Engl J Med. 2015;372(21):2018-2028.\u003C/li>\n        \u003Cli>DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. 11th Edition. Wolters Kluwer, 2019.\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\n\u003Cstyle>\n/* 全局样式区域 */\n.material-main-wrap {\n  font-family: 'Segoe UI', 'Arial', sans-serif;\n  background-color: #f5f9fa;\n  color: #19202a;\n  line-height: 1.8;\n  margin: 0 auto;\n  max-width: 850px;\n  padding: 32px 20px 40px 20px;\n  box-shadow: 0 2px 12px rgba(90,120,150,0.07);\n  border-radius: 18px;\n}\n\n.material-title {\n  font-size: 2.2em;\n  margin-bottom: 28px;\n  letter-spacing: 1.5px;\n  text-align: center;\n  color: #30475e;\n  font-weight: 700;\n}\n\n.material-intro-block,\n.material-section-block,\n.material-outro-block,\n.material-ref-block,\n.material-catalog-block {\n  margin-bottom: 32px;\n}\n\n.material-intro {\n  font-size: 1.12em;\n  margin-bottom: 10px;\n  text-align: left;\n}\n\n/* 目录样式 */\n.material-catalog-ul {\n  list-style: disc inside;\n  margin: 14px 0 0 10px;\n  padding-left: 6px;\n  color: #404550;\n}\n.material-catalog-ul li {\n  font-size: 1.07em;\n  margin-bottom: 5px;\n}\n\n/* 子标题和分块 */\n.material-subtitle {\n  font-size: 1.36em;\n  margin-top: 0px;\n  margin-bottom: 18px;\n  letter-spacing: 0.5px;\n  font-weight: 600;\n  color: #36a3be;\n  background: linear-gradient(90deg, #e2f5fb 70%, #c5ebff 100%);\n  border-radius: 11px;\n  display: inline-block;\n  padding: 5px 16px;\n  box-shadow: 0 1px 2px rgba(100,170,255,0.04);\n}\n\n/* 淡雅分块背景（每模块风格略有变化） */\n.material-block-bg {\n  background: linear-gradient(120deg, #eaf7fa 70%, #f5f9fa 100%);\n  border-radius: 10px;\n  padding: 22px 22px 20px 22px;\n  margin-bottom: 12px;\n  position: relative;\n}\n.material-bg-1 { background: linear-gradient(102deg, #f7fafc 70%, #e4f6f6 100%);}\n.material-bg-2 { background: linear-gradient(90deg, #f6fcff 80%, #e1effa 100%);}\n.material-bg-3 { background: linear-gradient(99deg, #e4f7fb 60%, #f4faff 100%);}\n.material-bg-4 { background: linear-gradient(93deg, #edf5f7 30%, #e7f7f2 100%);}\n.material-bg-5 { background: linear-gradient(90deg, #f1fafd 80%, #e7f1fb 100%);}\n.material-bg-6 { background: linear-gradient(100deg, #f7fafc 60%, #e7f6f9 100%);}\n.material-bg-7 { background: linear-gradient(97deg, #e9f5fc 60%, #f4f9ff 100%);}\n.material-bg-8 { background: linear-gradient(92deg, #fafbfa 60%, #eaf9fc 100%);}\n.material-bg-9 { background: linear-gradient(98deg, #eefbf7 55%, #e4f6f8 100%);}\n.material-bg-10 { background: linear-gradient(91deg, #f4fafb 70%, #e7f4fc 100%);}\n.material-bg-ref { background: linear-gradient(100deg, #f6f6ff 70%, #e6f7fb 100%); }\n\n/* 列表内步进与强调 */\n.material-ul {\n  margin: 0 0 0 10px;\n  padding-left: 14px;\n}\n.material-ul li {\n  margin-bottom: 10px;\n  font-size: 1.07em;\n}\n.material-ul ul {\n  margin-top: 3px;\n  margin-left: 20px;\n}\n.material-ul li b {\n  color: #397fa8;\n}\n\n/* 案例样式 */\n.material-case-block {\n  border-left: 4px solid #85cee9;\n  margin: 16px 0 6px 0;\n  background: #fafdff;\n  padding: 12px 17px;\n  font-size: 1.03em;\n  color: #397fa8;\n  border-radius: 5px;\n  position: relative;\n}\n.case-emoji {\n  font-size: 1.15em;\n  margin-right: 7px;\n}\n\n/* 焦点提示 */\n.material-focus {\n  font-weight: 500;\n  color: #dc9d22;\n  background: #fffbed;\n  padding: 8px 14px;\n  border-radius: 7px;\n  margin: 10px 0 0 0;\n}\n\n/* 章节小结 */\n.material-summary-title {\n  font-size: 1.22em;\n  font-weight: bold;\n  color: #39b0c0;\n  margin-bottom: 10px;\n}\n\n.material-summary-key {\n  font-size: 1.09em;\n  margin-top: 6px;\n  color: #274564;\n}\n\n.material-highlight {\n  color: #338ac6;\n  font-weight: bold;\n  font-size: 1.15em;\n  margin-right: 2px;\n}\n\n/* 参考文献部分 */\n.material-ref-title {\n  font-size: 1.07em;\n  color: #5f7291;\n  margin-bottom: 7px;\n}\n\n.material-ref-ol {\n  margin-left: 16px;\n  font-size: 1em;\n  color: #4d5a68;\n}\n.material-ref-ol li {\n  margin-bottom: 6px;\n}\n\n/* 响应式适配（可选） */\n@media (max-width: 600px) {\n  .material-main-wrap {padding: 5vw 2vw;}\n  .material-title {font-size: 1.2em;}\n  .material-block-bg{padding:12px 5px;}\n  .material-subtitle {font-size:1.1em;}\n}\n\u003C/style>\n\n","\u003Cdiv class=\"material-main-wrap\">\n  \n  \u003Ch1 id=\"material_title\" class=\"material-title\">肺鳞状细胞癌相关药品 | 用药",527,"2025-12-02 02:50:32","肺鳞状细胞癌T4N0M0常用药品全攻略：抓住用药关键，安全有效每一步","肺鳞状细胞癌, 免疫药物, 化疗药, 安全用药,药物相互作用, 用药管理,用药注意事项,常见副作用","本文详细解读肺鳞状细胞癌的免疫药物、化疗药物及其他辅助用药的安全使用要点与注意事项，帮助患者及家属掌握用药知识，提高治疗效果，实现安全有效用药。","2026-01-10 13:30:00",2,[35],{"menuId":36,"menuName":37,"parentId":21,"orderNum":33,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]